Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
|
Buy Now
Antibody-Drug Conjugates - The 21st Century Magic Bullets for Cancer (Hardcover, 2015 ed.)
Loot Price: R3,483
Discovery Miles 34 830
You Save: R863
(20%)
|
|
Antibody-Drug Conjugates - The 21st Century Magic Bullets for Cancer (Hardcover, 2015 ed.)
Series: AAPS Advances in the Pharmaceutical Sciences Series, 17
Expected to ship within 12 - 17 working days
|
This authoritative volume provides a holistic picture of
antibody-drug conjugates (ADCs). Fourteen comprehensive chapters
are divided into six sections including an introduction to ADCs,
the ADC construct, development issues, landscape, IP and
pharmacoeconomics, case studies, and the future of the field. The
book examines everything from the selection of the antibody, the
drug, and the linker to a discussion of developmental issues such
as formulations, bio-analysis, pharmacokinetic-pharmacodynamic
relationships, and toxicological and regulatory challenges. It also
explores pharmacoecomonics and intellectual properties, including
recently issued patents and the cost analysis of drug therapy. Case
studies are presented for the three ADCs that have received FDA
approval: gemtuzumab ozogamicin (Mylotarg (R)), Brentuximab vedotin
(Adcetris (R)), and ado-trastuzumab emtansine (Kadcyla (R)), as
well as an ADC in late-stage clinical trials, glembatumumab vedotin
(CDX-011). Finally, the volume presents a perspective by the
editors on the future directions of ADC development and clinical
applications. Antibody-Drug Conjugates is a practical and
systematic resource for scientists, professors, and students
interested in expanding their knowledge of cutting-edge research in
this exciting field.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.